Rockefeller Capital Management
RCUS icon

Rockefeller Capital Management’s Arcus Biosciences RCUS Stock Holding History

Rockefeller Capital Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$279K Buy
12,929
+705
+6% +$15.2K ﹤0.01% 2298
2025
Q4 		$291K Buy
12,224
+8,368
+217% +$171K ﹤0.01% 2172
2025
Q3 		$52.4K Buy
+3,856
New +$40.1K ﹤0.01% 2891
2023
Q1 		– Sell
-8,596
Closed -$177K – 3473
2022
Q4 		$177K Hold
8,596
– – ﹤0.01% 1720
2022
Q3 		$224K Sell
8,596
-129
-1% -$3.41K ﹤0.01% 1603
2022
Q2 		$220K Buy
+8,725
New +$214K ﹤0.01% 1597

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Rockefeller Capital Management's RCUS Position: Q1 2026 in Review

Rockefeller Capital Management increased its Arcus Biosciences (RCUS) stake by 5.8% in Q1 2026, buying an estimated $15.2K and bringing the position to 12,929 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #2298.

Rockefeller Capital Management first reported a position in RCUS in Q2 2022 and has held it in 6 quarters since. The position peaked at $291K in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Rockefeller Capital Management held 12,929 shares of Arcus Biosciences worth $279K as of Q1 2026.
  • Rockefeller Capital Management bought 705 Arcus Biosciences shares in Q1 2026, an estimated $15.2K.
  • Arcus Biosciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #2298 holding.
  • Rockefeller Capital Management first reported a position in Arcus Biosciences in Q2 2022 and has held it in 6 quarters since.
  • Rockefeller Capital Management's Arcus Biosciences position peaked at $291K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.